ProQR Therapeutics NV (PRQR)
2.26
+0.03
(+1.35%)
USD |
NASDAQ |
Dec 11, 12:21
ProQR Therapeutics EPS Diluted (Quarterly): -0.1221 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.376 |
| Merus NV | -1.262 |
| argenx SE | -- |
| Pharming Group NV | 0.109 |
| Pharvaris NV | -0.6971 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.86M |
| Revenue (Quarterly) | 3.368M |
| Total Expenses (Quarterly) | 16.23M |
| Enterprise Value | 126.48M |
| Gross Profit Margin (Quarterly) | 76.72% |
| Profit Margin (Quarterly) | -381.9% |
| Earnings Yield | -20.21% |
| Normalized Earnings Yield | -20.30 |